Yancopoulos, MD, Board Co-Chair, President & Chief Scientific Officer Number Of Employees: ~15,400 Stage: Public Financial Snapshot: The companys market cap as of July 2026 was $70.54 billion
watch now Eli Lilly CEO: Retatrutide will help those with BMI over 40 get to a healthy weight At the American Diabetes Associations 2026 Scientific Sessions, CNBCs Angelica Peebles sat down with Lilly CEO Dave Ricks to discuss exactly who could benefit from the high level of weight loss that the companys next-gen weight loss shot delivers
GLP-1 patches dont contain semaglutide, tirzepatide, or any other GLP-1 receptor agonist
It is worth sitting with what that implies about their ability to verify what they are shipping
Topics to be discussed at this hearing include: background on the diseases treated using GLP-1 drugs
Reduced Eating Frequency Patients using GLP-1s for chronic weight management commonly eat less and may eat less frequently